(Q34145853)

31 July 2017

title

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial (English)

1 reference

31 July 2017

1 reference

1 reference

9

Jean Wactawski-Wende

1 reference

31 July 2017

3

JoAnn E Manson

1 reference

31 July 2017

16

Marcia L Stefanick

1 reference

31 July 2017

11

Judith K Ockene

1 reference

31 July 2017

4

Ann G Schwartz

1 reference

31 July 2017

1

Rowan T Chlebowski

1 reference

31 July 2017

2

Garnet L Anderson

1 reference

31 July 2017

6

Margery Gass

1 reference

31 July 2017

13

F Allan Hubbell

1 reference

31 July 2017

10

Jane Morley Kotchen

1 reference

31 July 2017

5

Heather Wakelee

1 reference

31 July 2017

7

Rebecca J Rodabough

1 reference

31 July 2017

14

Jason W Chien

1 reference

31 July 2017

Karen C Johnson

8

1 reference

31 July 2017

Mary Jo O'Sullivan

series ordinal

12

1 reference

31 July 2017

Chu Chen

series ordinal

15

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 August 2010

1 reference

Journal of the National Cancer Institute

31 July 2017

published in

1 reference

31 July 2017

volume

102

1 reference

31 July 2017

issue

18

1 reference

31 July 2017

page(s)

1413-1421

1 reference

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Breast cancer after use of estrogen plus progestin in postmenopausal women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Hormone replacement therapy is associated with decreased survival in women with lung cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Endometrial cancer and hormone-replacement therapy in the Million Women Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Hormonal factors and risk of lung cancer among women?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Estrogen-progestin replacement therapy and endometrial cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Hormone replacement therapy and lung cancer risk: a case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Menopausal hormone therapy, hormone receptor status, and lung cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Implementation of the women's health initiative study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Estrogen plus progestin and colorectal cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

Reduced mortality associated with long-term postmenopausal estrogen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ285

The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943522

Outcomes ascertainment and adjudication methods in the women's health initiative

28 October 2018

1 reference

12 December 2020

Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women

1 reference

12 December 2020

The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group

1 reference

12 December 2020

Estrogen and progesterone receptors in bronchogenic carcinoma

1 reference

12 December 2020

Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer

1 reference

12 December 2020

Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study

1 reference

12 December 2020

Re: Endocrine factors and adenocarcinoma of the lung in women

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJQ285

1 reference

31 July 2017

1 reference

31 July 2017

1 reference